InSphero is a spin-off of ETH Zurich and the University Zurich. It is the first commercial producer of organotypic, scaffold-free, 3D microtissues for drug development and screening. In particular, InSphero thereby provides solutions to pharmaceutical and biotechnological companies in the fields of oncology and toxicology.
The company was selected for the Venture Kick Initiative (2009), was awarded the CTI Start-up Label (2010), ranked amongst Switzerland’s Top 10 Start-ups from 2011-2013 and finally was elected Switzerland’s Top Start-up as well as Europe’s Top Life Sciences Academic Enterprise in 2014.
Jan Lichtenberg, CEO and co-founder of InSphero, will talk about his background, his experience in entrepreneurship, and his journey towards founding and running his own start-up.
September 09, 2016
Science lounge, D-BSSE
Mattenstrasse 26, Basel, Switzerland
Talk "Jan Lichtenberg & InSphero - from lab bench to a global biotech start-up"
by Dr. Jan Lichtenberg (CEO) of InSphero